Aarti Industries Reports ₹106 Crore Net Profit in Q2 FY26

Aarti Industries announced its Q2 FY26 results on November 6, reporting strong growth in profitability and improved operating margins alongside steady revenue expansion.
Key Financial Highlights
- Net Profit: ₹106 crore vs ₹52 crore in Q2 FY25
- Revenue: ₹2,100 crore, up 12% YoY from ₹1,628 crore
- EBITDA: ₹291 crore, up 47.7% YoY
- EBITDA Margin:9% vs 12.1% in Q2 FY25
The improvement in margins was supported by better realisations and operational efficiencies.
Strategic Partnership with DCM Shriram
Last month, Aarti Industries entered into a long-term agreement with DCM Shriram Ltd for chlorine supply. Under the arrangement, chlorine will be supplied from DCM Shriram’s Jhagadia plant to Aarti’s upcoming downstream facility via a dedicated underground pipeline.
The partnership aims to enhance supply security and integration for Aarti’s operations, improving efficiency and reliability in chemical manufacturing processes.
Performance Overview
The company highlighted progress in sustainable manufacturing and advanced process capabilities. Shares of Aarti Industries ended higher on November 6, closing at ₹390.00 on the NSE, up 1.27% from the previous session.
Read More: Aarti Industries Q1 FY26 Results: Rev ₹1,867 Crore.
Conclusion
Aarti Industries delivered improved profitability and margin expansion in Q2 FY26, supported by revenue growth and operational efficiencies. With strategic partnerships and capacity expansion, the company remains focused on sustaining growth in the speciality chemicals segment.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Nov 6, 2025, 7:40 PM IST

Akshay Shivalkar
Akshay Shivalkar is a financial content specialist who strategises and creates SEO-optimised content on the stock market, mutual funds, and other investment products. With experience in fintech and mutual funds, he simplifies complex financial concepts to help investors make informed decisions through his writing.
Know More- Stocks to Watch Today: Gland Pharma, Power Grid, Rail Vikas Nigam and Others (September 4, 2026)
- Sensex Slips Below 76,100 Mark in Intraday Trade on September 7, 2026
- Stocks to Watch Today: RVNL, Cohance Lifesciences, Molbio Diagnostics and Others (September 7, 2026)
- Adani Defence Signs Five-Year Ammunition Supply Agreement for AK-203 Programme
- AstraZeneca Gains FDA Approval for Camizestrant Combo in ESR1-Mutated Advanced Breast Cancer


